Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma

Autor: Allen, Pamela B. 1, ∗, Lu, Xinyan 2, Chen, Qing 2, O’Shea, Kaitlyn 2, Chmiel, Joan S. 2, Slonim, Liron Barnea 2, Sukhanova, Madina 2, Savas, Hatice 2, Evens, Andrew M. 3, Advani, Ranjana 4, Pro, Barbara 2, 5, Karmali, Reem 2, Palmer, Brett 2, Bayer, Robert A. 2, Eisner, Robert M. 2, Mou, Eric 4, 6, Dillehay, Gary 2, Gordon, Leo I. 2, Winter, Jane N. 2
Zdroj: In Blood Advances 27 June 2023 7(12):2670-2676
Databáze: ScienceDirect